Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)

SHE:000403 Revenue

Pacific Shuanglin Bio-pharmacy had revenue of 573.28M CNY in the quarter ending September 30, 2026, a decrease of -9.24%. This brings the company's total for the last twelve months to 2.42B, up 1.47% year-over-year. In the year 2025, Pacific Shuanglin Bio-pharmacy had annual revenue of 2.63B, down -0.83%. That makes Pacific Shuanglin Bio-pharmacy the 13,194th largest company in the world by revenue and 2,307th in China.

• Revenue (ttm): 2.42B
• Revenue Growth: +1.47%
• P/S Ratio: 3.69
• Revenue / Employee: 877.53K
• Employees: 2,755
• Market Cap: 9.01B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Industry 2.63B 100.0%
• Unallocated Others 1.14M 0.0%

By Geography

Chart

• China 2.63B 99.8%
• Foreign 4.46M 0.2%

Fiscal year ended Dec 31, 2025 See the full SHE:000403 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.63B	-22.08M	-0.83%
Dec 31, 2024	2.65B	325.96M	14.00%
Dec 31, 2023	2.33B	-76.47M	-3.18%
Jan 1, 2023	2.41B	433.45M	21.98%
Jan 1, 2022	1.97B	921.80M	87.80%

Data Source: S&P Global Market Intelligence Last updated: Oct 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error